# FDA Inspection 1126557 - Novacyl Roussillon - March 02, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/novacyl-roussillon/afedfb6c-c6ee-4b3b-836e-acccbafe9ac2
Source feed: FDA_Inspections

> FDA Inspection 1126557 for Novacyl Roussillon on March 02, 2018. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1126557
- Company Name: Novacyl Roussillon
- Inspection Date: 2018-03-02
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1275836 - 2023-02-02](https://www.globalkeysolutions.net/records/fda_inspections/novacyl-roussillon/8053a39f-6c44-4672-98fc-0c9767416ef5)
- [FDA Inspection 983907 - 2016-06-30](https://www.globalkeysolutions.net/records/fda_inspections/novacyl-roussillon/85951a94-db0c-4c71-8f2e-2935c67a77aa)
- [FDA Inspection 886692 - 2014-07-04](https://www.globalkeysolutions.net/records/fda_inspections/novacyl-roussillon/05e450ba-f84b-49f2-85c6-84b539d77284)

Company: https://www.globalkeysolutions.net/companies/novacyl-roussillon/5a1bc6b5-5b17-4058-9698-82735b553d87

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c